Andrew M.Teal

Associate

亚特兰大 + 1.404.581.8236

Andrew Teal practices corporate law, with a focus on M&A and corporate governance. He advises public and private companies, as well as private equity firms, in domestic and cross-border mergers, acquisitions, divestitures, and other complex and strategic transactions. His clients range in size from start-ups to Fortune 500 public companies, and he has experience advising clients across various industries including biotechnology, aerospace, manufacturing, energy, finance, and marketing.

Andrew's representative matters include: The Stephens Group's acquisition of VisionSafe Corporation; Koch Equity Development's preferred equity investment in Maxar Technologies; The Stephens Group's sale of a portfolio company, Summit Industrial Construction; and restor3d's Series A preferred stock offering in an aggregate capital amount of up to $50 million.

While in law school, Andrew worked at an entrepreneurial law clinic where he advised start-ups on corporate law issues including business formation and corporate governance.

经验

  • Ensign-Bickford Industries acquires Accratronics SealsJones Day advised Ensign-Bickford Industries, Inc. in connection with its acquisition of Accratronics Seals LLC (formerly Accratronics Seals Corporation), a family-owned and operated, end-to-end machine shop which specializes in the creation of hermetically sealed connectors and parts for the aerospace, defense, and space travel industries.
  • The Stephens Group sells Summit Industrial Construction to Comfort Systems USAJones Day is advising The Stephens Group, LLC in the sale of portfolio company, Summit Industrial Construction, LLC, to Comfort Systems USA, Inc.
  • Asbury Automotive Group acquires Jim Koons AutomotiveJones Day advised Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S., in its acquisition of Jim Koons Automotive Group of Companies for approximately $1.2 billion in cash.
  • restor3d acquires Conformis, Inc.Jones Day advised restor3d, Inc., a leading personalized 3D-printed orthopedic company, on its acquisition of Conformis, Inc. (NASDAQ: CFMS), a leading medical technology company focused on orthopedic patient care.
  • Roper Technologies subsidiary acquires business of RepliconJones Day advised Roper Technologies, Inc. in the acquisition by subsidiary Deltek, the leading global provider of software and solutions for project-based businesses, of the business of Replicon, Inc., a provider of unified time tracking solutions that bring together Project Delivery, Finance, and HR on a single platform, purpose-built for project and services-centric organizations.
  • Focused Cryo raises $2.5 million in convertible debt financingJones Day advised Focused Cryo, Inc. in raising $2.5 million from accredited investors in a convertible debt financing.
  • Riverside portfolio company acquires Primary IntelligenceJones Day represented The Riverside Company in connection with the acquisition by portfolio company Corporate Visions of Primary Intelligence, a provider of SaaS-based win-loss analysis solutions for B2B companies.
  • Accelmed Partners leads $30 million private placement of Common Stock issued by Minerva Surgical, Inc.Jones Day represented Accelmed Partners in connection with its purchase of $30 million of Common Stock in a private placement issued by Minerva Surgical, Inc., granting Accelmed Partners a controlling stake in Minerva Surgical.
  • Nutrien completes US$1 billion Senior Unsecured Notes offeringJones Day represented Nutrien Ltd. in connection with a public offering of US$1 billion of Senior Notes, consisting of (i) US$500 million aggregate principal amount of 5.900% Senior Notes due 2024 and (ii) US$500 million aggregate principal amount of 5.950% Senior Notes due 2025.